Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
5.02
-0.12 (-2.24%)
Apr 27, 2026, 2:34 PM EDT - Market open
Protara Therapeutics Market Cap
Protara Therapeutics has a market cap or net worth of $271.23 million as of April 27, 2026. Its market cap has increased by 84.42% in one year.
Market Cap
271.23M
Enterprise Value
82.92M
1-Year Change
84.42%
Ranking
Category
Stock Price
$5.02
Market Cap Chart
Since January 10, 2020, Protara Therapeutics's market cap has increased from $173.16M to $271.23M, an increase of 56.64%. That is a compound annual growth rate of 7.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 277.45M | -2.86% |
| Dec 31, 2025 | 285.62M | 12.67% |
| Dec 31, 2024 | 253.49M | 1,089.52% |
| Dec 29, 2023 | 21.31M | -29.43% |
| Dec 30, 2022 | 30.20M | -60.18% |
| Dec 31, 2021 | 75.84M | -72.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Minerva Neurosciences | 288.26M |
| Editas Medicine | 284.81M |
| NovaBridge Biosciences | 283.34M |
| Zentalis Pharmaceuticals | 282.31M |
| AC Immune | 281.73M |
| C4 Therapeutics | 281.03M |
| Cellectis | 280.95M |
| Cybin | 280.70M |